Clinical studies of the efficacy and tolerability of ebastine 10 or 20 mg once daily in the treatment of seasonal allergic rhinitis in the US

Drugs

Volumn 52, Issue SUPPL. 1, 1996, Pages 20-25

  Storms, William W ^a  

^a Asthma & Allergy Associates PC and Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EBASTINE;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ASTHENIA; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SOMNOLENCE; SYMPTOMATOLOGY; UNITED STATES; XEROSTOMIA;

EID: 0029740237     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199600521-00006     Document Type: Review

References (8)

1. Philip G, Togias AG. Allergic rhinitis: today's approach to treatment. J Respir Dis 1995; 16 (4): 367-72
2. International consensus report on the diagnosis and management of rhinitis. Allergy 1994; 49 Suppl. 19: 5-34
3. Middleton E, Reed CE, Ellis ES, et al. editors. Allergy: principles and practice. 4th ed. St Louis: C.V. Mosby, 1993
4. Vallés CP, Garcia AC, Bahima AC, et al. Ebastine in perennial rhinitis. Ann Allergy 1991; 67: 615-8
5. Ankier SI, Warrington SJ. A double-blind placebo-controlled study of the efficacy and tolerability of ebastine against hay fever in general practice patients. J Intern Med 1989; 226: 453-8
6. 1 antihistamines. Ann Allergy 1991; 67 (5): 541-7
7. Meltzer EO. Comparative safety of antihistamines. Ann Allergy 1991; 67 (6): 625-33
8. Wiseman LR, Faulds D. Ebastine: a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders. Drugs 1996; 51 (2): 260-77